HuD Promotes Progression of Oral Squamous Cell Carcinoma
Authors:
- Miyako KuriharaMKMiyako Kurihara
- Kazuhiko YamamotoKYKazuhiko Yamamoto
- Nobuhiro UedaNUNobuhiro Ueda
- Chie NakashimaCNChie Nakashima
- Sayako MatsushimaSMSayako Matsushima
- Ujjal K. BhawalUBUjjal K. Bhawal
- Tadaaki KiritaTKTadaaki Kirita
- Hiroki KuniyasuHKHiroki Kuniyasu
- 23 September 2014
- journal article
- research article
- Published by S. Karger AG in Pathobiology
- Vol. 81 (4) , 206-214
Abstract
Head and neck cancer, including oral squamous cell carcinoma (OSCC), ranks as the sixth most common malignancy worldwide. Overall 5-year survival rates of OSCC have not significantly improved during the past 3 decades and the 5-year survival rate is less than 50%. Several invasion grading systems have been employed in OSCC, however, their utility is still controversial. HuD belongs to the Hu protein family and acts as an RNA-binding protein involved in mRNA stability and translational regulation. Although HuD has a pivotal role for neuronal differentiation, the functional role of HuD in OSCCs is still unclear. In this study, we examined HuD expression in 82 OSCC cases. Expression of HuD was observed in 36.6% of OSCCs and significantly associated with histological differentiation, nodal metastasis and mode of invasion. HuD expression in high-metastatic HSC3 cells was higher than in low-metastatic HSC4 cells, and inhibition of invasion ability and activation of caspase-3 were shown by HuD siRNA-treated HSC3 cells. Furthermore, we clarified that HuD regulates expression of vascular endothelial growth factor (VEGF)-A, VEGF-D, matrix metallopeptidase (MMP)-2 and MMP-9. These results suggest that HuD is a useful diagnostic and therapeutic target in OSCCs.Keywords
This publication has 25 references indexed in Scilit:
- miR-375 Inhibits Differentiation of Neurites by Lowering HuD LevelsMolecular and Cellular Biology, 2010
- Molecular analysis of the HuD gene in neuroendocrine lung cancersLung Cancer, 2010
- Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2009
- Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cellsJournal of Clinical Investigation, 2009
- High mobility group box‐1‐inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinomaCancer Science, 2008
- Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinomaHistopathology, 2007
- Notch3 and the Notch3‐upregulated RNA‐binding protein HuD regulate Ikaros alternative splicingThe EMBO Journal, 2007
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- nm23-H1 Suppresses Invasion of Oral Squamous Cell Carcinoma-Derived Cell Lines without Modifying Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 ExpressionThe American Journal of Pathology, 2001
- Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavityHead & Neck Surgery, 1984